Journal of Cytokine Biology
Open Access

Wound healing is a complex orchestra of events which results in tissue remodelling and a complete closure of wound with minimal skin damage. It involves cell migration, proliferation and deposition of extracellular matrix (ECM), angiogenesis and finally tissue remodelling [1,2,3]. This sequence of events are hampered and deregulated in case of chronic wounds like diabetic foot ulcers. Recent advances in addressing this pressing issue has resulted in unsatisfactory results and failed to prevent morbidity and disability associated with such chronic wounds. Current treatment achieve only about 50% success and their effects are not permanent [2]. Defective cytokine production by local inflammatory cells and fibroblasts, reduced angiogenesis are crucial factors which dominate chronic non healing wounds and pose daunting obstacles to overcome.

Mesenchymal stem cells (MSC) are multipotent cells which have demonstrated wound healing properties in a number of clinical trials. The mechanism of action of MSCs can be attributed to either their ability to transdifferentiate or through their paracrine effects. The ISCT (International Society for Cellular Therapy) definition of MSC is its ability to differentiate into osteocytes, chondrocytes and adipocytes, plus its surface expression of CD73,CD105 and CD90 [4]. Bone marrow MSC have limited ability to differentiate in vitro and lose this ability within a few passages in culture [5], whereas Umbilical Cord Derived MSC (UC-MSC) have shown to retain the ability of differentiation and surface markers upto 108 doublings [4].The paracrine effects of MSC known to promote wound healing are soluble growth factors like Stromal cell Derived Factor 1 (SDF1), Vascular Endothelial Growth Factor (VEGF), Platelet Derived Growth Factor (PDGF), Interleukin 8 (IL8) which supersede its ability to differentiate in the wound area.

In the present study, we attempt to delineate the 2 properties of MSC viz : ability to differentiate and its ability to produce wound healing soluble factors, which could be primarily far more important than its ability to differentiate. Since BM-MSC and UC-MSC have different "stemness" properties in vitro, with UC-MSC retaining the stem like properties in late passages (passage 18, doubling 108) when compared to BM-MSC, it is important to also study whether the 2 kinds of MSCs can still produce soluble factors which are essential for wound healing.

We demonstrate that both BM-MSC and UC-MSC retain their ability to produce Platelet Growth Factor (PDGF), Interleukin 8 (IL-8), Vascular Endothelial Factor (VEGF), Stromal Cell Derived Growth Factor (SDF1), into mid passages in vitro (with Fetal bovine serum), and is in sync with their ability to differentiate into chondrocytes, adipocytes and osteocytes. Their ability to produce these factors decreases significantly by mid passage which correlates with its inability to differentiate.

Mesenchymal stem cells isolation and culture

Umbilical cords (UC) were obtained after informed consent was signed by healthy volunteers (Ethical clearance was given by Institutional Committee for Stem cell Research and Therapy (ICSRT): 132/CHE/2010 A – Number 272353). UCs were collected and processed within 48 h of delivery and Bone marrow MSCs (BM-MSCs) were obtained from Lonza. Umbilical derived Mesenchymal Stem cells (UC-MSCs) were isolated and cultured as described previously [6] in 20% Fetal Bovine Serum (FBS) containing Dulbecco’s Modified Eagle’s Medium (DMEM F12) (Gibco). Adherent cells were passaged upon reaching 80% confluency and reseeded at the density of 1000 cells/cm² in 75 cm² for further expansion. Medium was changed every 2-3 days and cells were maintained in a humidified atmosphere at 5% CO₂ at 37°C. Viable cells were counted using trypan blue stain (Sigma) and Passage 3 (P3) cells (BM-MSCs and UC-MSCs) were used for the experiment.

BM-MSCs and UC-MSCs were cultured at the density of 1000 cells/cm² in 4 wells of 24 wells plate and sub-cultured till passage 16 (P16). P3, P5 and P16 cells were used for differentiation using adipogenic, chondrogenic and osteogenic differentiation medium and stained after 25 days for Oil Red, Alcian blue and Alizarin Red, respectively.

Protein estimation and cytokines detection

Supernatants were collected at every passage (P3-P16) for MSCs and stored at -80˚C until used. Total protein content in the samples was measured by Biuret method. PDGF, VEGF, SDF-1 and IL-8 levels were determined using ELISA (Ray Bio).

Statistics

All values were expressed as mean ± standard error mean (SEM).

UC MSC and BM MSC cells were cultured in 20% FBS containing DMEM from P3 to P16 and supernatants were collected for all the passages. Levels of PDGF, VEGF, SDF-1 and IL-8 has significantly decreased after passage 8 in both BM MSC and UC MSC supernatants as shown in Figures 1-4, which is correlating with the differentiation potential of the cells as shown in Table 1. Also, BM MSC shows decreased amount of cytokine levels in comparison with UC MSC, wherein VEGF concentrations are seemingly negligible in BM MSC supernatants.

Table 1: Ability of UC-MSCs and BM-MSCs for differentiation

Figure 1: Graphical representation of PDGF levels in UC-MSCs and BM-MSCs supernatants (P3-P16)

Figure 2: Graphical representation of VEGF levels in UC-MSCs and BM-MSCs supernatants (P3-P16)

Figure 3: Graphical representation of SDF-1 levels in UC-MSCs and BM-MSCs supernatants (P3-P16)

Figure 4: Graphical representation of IL-8 levels in UC-MSCs and BM-MSCs supernatants (P3-P16)

Mesenchymal stem cells (MSC) are multipotent stem cells which are derived from various sources such as bone marrow, adipose tissue and Umbilical cord. They are spindle shaped adherent population, are immuno-modulatory by nature and are very efficient cells for wound healing. They can differentiate into adipocytes, chondrocytes and osteocytes [4]. They can also differentiate into hepatocytes, cardiomyocyte, astrocyte and neuron [5,7,8].

MSC have shown great promise in regenerative medicine, especially areas affected due to injury /ischemia. MSC migrate to area of ischemic stroke [9] and repair the affected area either by differentiation, cell replacement or paracrine effects or both.

Preclinical studies have demonstrated the efficacy of MSC in wound healing such as excision wound [10], diabetic foot ulcers [11], pressure ulcers [12] and burn injury [13]. MSCs improve wound healing and promote scar- less recovery by accelerating collagen synthesis and angiogenesis. Safety and efficacy of MSC in clinical trials have demonstrated that MSC produce no adverse events and are efficient in the treatment of non-healing ulcers [11], limb ischemia [14] diabetic foot ulcers [10] and radiation burn [15]. Clinically tangible end points like significant increase in angiogenesis and reduction in inflammatory milieu have been effectively demonstrated. The mechanism of action of MSC to produce these clinical effects could be attributed to either their trans differentiation into parenchymal cells [16] or their ability to produce a host of growth factors and cytokines which could result in a paracrine effect [17].

The aim of the study was to delineate the "stem-like" properties exhibited by MSCs and correlate it to its ability to produce soluble factors like VEGF, PDGF, SDF1, IL-8, which are historically known to promote wound healing. We studied two sources of MSC, BM MSC derived from bone marrow, the other was Umbilical Cord derived MSC and the parameters of analysis was its ability to display stem like properties of differentiation and its ability to produce soluble factors which promote wound healing. We observe that BM MSC and Cord derived MSC lose their property of differentiation within 5 passages (16.6 doubling) which coincides with its inability to produce paracrine factors.

We chose four cytokines: viz. Platelet Growth Factor (PDGF), Interleukin 8 (IL-8), Vascular Endothelial Factor (VEGF), Stromal Cell Derived Growth Factor (SDF1) for this study. VEGF promotes endothelial cell motility, proliferation and survival, Endothelial precursors (EPC) mobilization and homing, promotes integrin expression and up regulates vasculogenic cytokines. SDF1 is implicated in EPC recruitment. PDGF is implicated in EPC migration and expansion [18]. IL-8 attracts polymorph nuclear leukocytes and helps in epidermal wound healing.

MSCs have an innate ability to heal wounds and are effective in all the phases of wound healing. The first phase which is inflammatory phase is when the wound occurs. MSCs exert an immunosuppressive milieu which regulates proliferation of T cells, B cells NK cells [19-25]. The next phase of wound healing i.e., proliferation occurs 2-3 days which results in re-epithilization and angiogenesis. Wounds treated with MSC (BM MSC or Adipose Derived MC), have resulted in increased re-epithelialisation, angiogenesis, and granulation tissue formation [26-33].

Mechanism of action of MSCs is shown to be both by differentiation and paracrine signalling in the proliferation phase. That MSC differentiate into either fibroblasts, endothelial cells, pericytes [34,35] and epidermal keratinocytes [26,29,33] have been demonstrated in studies involving fluorescent labelled BM MSC injected either topically or intravenously, in mouse models. Co-culture experiments involving BM MSC and heat shocked sebaceous glands resulted in differentiation of MSC to sebaceous glands in skin near the wound area [31], although the engraftment is low and decreases with time. However the observations are not conclusive as there is difference of opinion wherein many studies have refuted this differentiation of MSCs near the wound area [28]. Additionally, most studies have indicated co localization of GFP with specific cell markers, implicating fusion of MSC with these resident cells as a possible mechanism, rather than differentiation [36].

There is growing evidence that the predominant mechanism for wound healing mediated by BM MSC, Adipose MSC, Umbilical cord MSC [37-40] is by secreted factors like PDGF, VEGF, SDF1, IL-8 and chemokines, which promote and accelerate re-epithelialisation and wound repair [33,37,41]. MSC secrete exosomes which helps in activation, migration and proliferation of different cells involved in wound healing which would promote angiogenesis, epithelialisation and proliferation of fibroblast.

In our study we have demonstrated that the differentiation ability and paracrine modalities of BM MSC and Umbilical cord derived MSC are correlated with each other. BM MSC and Cord Derived MSC exhibit significantly low amounts of PDGF, IL 8, SDF1 and VEGF by mid passage, as shown in Figures 1-4 which is when they also are unable to differentiate, in our culture conditions (Table 1). We have demonstrated BM-MSCs and UC-MSCs gradually lose their stemness properties in vitro and it seems to be correlated to their ability to produce paracrine soluble factors crucial for wound healing. Further studies to improve culture conditions will help elucidate more effective methods to improve the regenerative potentials of MSCs.